• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Enhancing MRI Efficiency and Quality: Can the New SIGNA Experience Have an Impact?

Article

Recently launched at the Radiological Society of North America (RSNA) conference, the SIGNA Experience reportedly features synergistic technologies and artificial intelligence (AI) advances that help improve the efficiency and quality of magnetic resonance imaging.

Offering the potential benefits of streamlined scanning and intelligent automation in magnetic resonance imaging (MRI), GE Healthcare recently launched the SIGNA Experience, which combines imaging software, artificial intelligence (AI) applications and automated workflow technologies into one platform.

GE Healthcare said the four primary components of the SIGNA Experience include enhanced image quality through the next-generation imaging software SIGNA One (available on SIGNA Prime); deep learning AI applications (including AIR Recon DL) that facilitate shorter scan times and improved signal-to-noise (SNR) ratios; flexible, lightweight AIR Coils; and automated workflow technologies, such as AIRTouch, that simplify scan set-up.

The SIGNA Experience also offers visually highlighted fields for step-by-step guidance, minimal clicks to complete the MRI exam and an intuitive workflow that accommodates a variety of experience levels, according to GE Healthcare.

“SIGNA Experience was designed in response to today’s industry pressures to help achieve operational efficiency and simplicity as clinicians face a significant volume of non-urgent backlog scans caused largely by the impact of COVID-19, radiologist shortages and staff burnout,” explained Jie Xue, the president, and CEO of Magnetic Resonance for GE Healthcare. “These technologies enable scanner operators of all skill levels to get the job done without compromising quality and output.”

Recent Videos
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Related Content
© 2024 MJH Life Sciences

All rights reserved.